Then, transcriptome sequencing results showed that the MAPK signaling pathway was activated in EGFRvIII mutant GBM, and ERK/c-Fos, as a key downstream regulatory molecule of this signaling pathway, could directly regulate the expression of downstream targeted genes (Fig. 3B–D). The gene discussed is FOS; the disease is glioblastoma.